Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas: A Prospective Double Blinded Placebo Controlled Study

NCT01147601 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT01147601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01147601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas: A Prospective Double Blinded Placebo Controlled Study
Lead sponsor
Oregon Health and Science University
Phase
Phase 1
Overall status
Terminated
Start date
March 31, 2010
Completion date
August 31, 2014
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemangioma, infant